Jan Schmidt-Brand
Corporate Officer/Principal bei BIOPRO Baden-Württemberg GmbH
Profil
Jan Schmidt-Brand currently works at BIOPRO Baden-Württemberg GmbH, as Deputy Member-Supervisory Board.
Dr. Schmidt-Brand also formerly worked at Heidelberg Pharma AG, as Chief Executive Officer from 2023 to 2024, BIO Deutschland, as Director & Head-Finance & Tax from 2007 to 2019, EBEWE Arzneimittel GmbH, as Managing Director from 1997 to 2001, Heidelberg Pharma Research GmbH, as Managing Director from 2004 to 2024, BASF SE, as Principal, Knoll AG, as Principal, and Heidelberg Pharma AG, as Chief Executive & Financial Officer.
Dr. Schmidt-Brand received his doctorate degree from the University of Mannheim.
Aktive Positionen von Jan Schmidt-Brand
| Unternehmen | Position | Beginn |
|---|---|---|
BIOPRO Baden-Württemberg GmbH
 BIOPRO Baden-Württemberg GmbH Miscellaneous Commercial ServicesCommercial Services BIOPRO Baden-Württemberg GmbH provides business support services to research institutions. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jan Schmidt-Brand
| Unternehmen | Position | Ende |
|---|---|---|
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Chief Executive Officer | 01.02.2024 |
| HEIDELBERG PHARMA AG | Chief Executive Officer | 01.02.2024 |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Director of Finance/CFO | 01.01.2019 |
| EBEWE Arzneimittel GmbH | Chief Executive Officer | 01.01.2001 |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Corporate Officer/Principal | - |
Ausbildung von Jan Schmidt-Brand
| University of Mannheim | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BASF SE | Process Industries |
| HEIDELBERG PHARMA AG | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Health Technology |
BIO Deutschland
BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Commercial Services |
| EBEWE Arzneimittel GmbH | |
BIOPRO Baden-Württemberg GmbH
BIOPRO Baden-Württemberg GmbH Miscellaneous Commercial ServicesCommercial Services BIOPRO Baden-Württemberg GmbH provides business support services to research institutions. | Commercial Services |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Commercial Services |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
